Sangamo Therapeutics
SGMO
#8680
Rank
HK$1.40 B
Marketcap
HK$4.18
Share price
4.39%
Change (1 day)
-56.36%
Change (1 year)

EPS for Sangamo Therapeutics (SGMO)

EPS in 2025 (TTM): -HK$3.43

According to Sangamo Therapeutics 's latest financial reports the company's current EPS (TTM) is -HK$3.44. In 2024 the company made an earnings per share (EPS) of -HK$3.98.

EPS history for Sangamo Therapeutics from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$3.43-13.99%
2024-HK$3.98
2022-HK$9.770.81%
2021-HK$9.6933.33%
2020-HK$7.276.9%
2019-HK$6.8022.54%
2018-HK$5.551.43%
2017-HK$5.47-31.37%
2016-HK$7.9775.86%
2015-HK$4.5348.72%
2014-HK$3.05-17.02%
2013-HK$3.679.3%
2012-HK$3.36-39.44%
2011-HK$5.55

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$81.56-2,472.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$101.80-3,061.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
HK$85.86-2,597.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
-HK$12.66 268.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
HK$50.94-1,581.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$59.33-1,825.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
HK$0.70-120.45%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
HK$21.25-718.18%๐Ÿ‡บ๐Ÿ‡ธ USA